Regeneron Announces Upcoming 2013 Investor Conference Presentations
TARRYTOWN, N.Y., May 8, 2013
TARRYTOWN, N.Y., May 8, 2013 /PRNewswire/ --Regeneron Pharmaceuticals, Inc.
(NASDAQ: REGN) will webcast management presentations at the following investor
oUBS Global Healthcare Conference on Monday, May 20, 2013. The
presentation is scheduled for 10:00 a.m. Eastern Time.
o38^th Annual dbAccess Healthcare Conference on Wednesday, May 29, 2013.
The presentation is scheduled for 8:40 a.m. Eastern Time.
oJefferies 2013 Healthcare Conference on June 3, 2013. The presentation is
scheduled for 9:00 a.m. Eastern Time.
oGoldman Sachs 34^th Annual Global Healthcare Conference on Tuesday, June
11, 2013. The presentation is scheduled for 11:40 a.m. Eastern Time (8:40
a.m. Pacific Time).
The presentations may be accessed through the Company's web site,
www.regeneron.com, on the 'Events and Presentations' page. An archived
version of the presentations will be available for 30 days.
About Regeneron Pharmaceuticals, Inc.
Regeneron is a leading science-based biopharmaceutical company based in
Tarrytown, New York that discovers, invents, develops, manufactures, and
commercializes medicines for the treatment of serious medical conditions.
Regeneron markets medicines for eye diseases, colorectal cancer, and a rare
inflammatory condition and has product candidates in development in other
areas of high unmet medical need, including hypercholesterolemia, oncology,
rheumatoid arthritis, allergic asthma and atopic dermatitis. For additional
information about the company, please visit www.regeneron.com.
Manisha Narasimhan, Ph.D. Peter Dworkin
Investor Relations Corporate
SOURCE Regeneron Pharmaceuticals, Inc.
Press spacebar to pause and continue. Press esc to stop.